| (Values in U.S. Thousands) | Jun, 2022 | Mar, 2022 | Sep, 2021 | Jun, 2021 | Mar, 2021 |
| Sales | 834 | 1,816 | 2,275 | 2,105 | 3,044 |
| Sales Growth | -54.07% | -20.18% | +8.08% | -30.85% | +34.99% |
| Net Income | -1,863 | -3,317 | -13,167 | -9,144 | -13,956 |
| Net Income Growth | +43.83% | +74.81% | -44.00% | +34.48% | -382.24% |
Emerald Health Therapeutics Inc (EMH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Emerald Health Therapeutics Inc is engaged in the production, distribution, and sale of cannabis products in Canada.
Fiscal Year End Date: 12/31